SOPs for COVID-19 Vaccines

Standard Operating Procedures to support the management of COVID-19 vaccines at vaccination clinics

Please refresh your webpage to see the most up to date information

• SOP - Guidance at sites for management of Comirnaty for 12 years of age and older Including: Comirnaty 30 micrograms/dose concentrate for dispersion for injection – Purple cap, Comirnaty 30 micrograms/dose dispersion for injection - Grey cap, Comirnaty Original/Omicron BA.1 (15/15 micrograms)/dose dispersion for injection- Grey cap and SOP - Guidance at sites for management of Comirnaty 10 micrograms/dose concentrate for dispersion for injection for children 5 to 11 yearsVersion 12.0 19 September 2021
• SOP - Management of Spikevax® (previously COVID-19 Vaccine) Moderna and Spikevax Original/Omicron BA.1 Guidance Version 9.0 16 September 2022 
• SOP - Management of JCOVDEN (JANSSEN COVID‐19) Vaccine Guidance at vaccination Clinics Version 6.0 8 August 2022
• SOP - Management of Nuvaxovid® (COVID-19 vaccine Novavax) Version 2.0 8 August 2022

If you require a copy of a reconciliation form please contact our office by email. Please include the setting and the vaccine type to help us to send you the correct form.

Please note if you are using TrackVax Vaccine Reconciliation should be done through this system instead.

There are 2 Comirnaty® (Pfizer/BioNTech) Vaccines available in Ireland. Ensure the correct vaccine is given to the correct people by referring to the Comirnaty® (Pfizer/BioNTech) Vaccine Formulations Guide Version 2

Go back to COVID-19 Vaccine Information for Health Professionals

This page was added on 19 September 2022